Analysis of promoter regions regulating basal and interleukin-4-inducible expression of the human CB1 receptor gene in T lymphocytes

Molecular Pharmacology

Volumn 73, Issue 3, 2008, Pages 1013-1019

  Börner, Christine ^a   Bedini, Andrea ^a   Höllt, Volker ^a   Kraus, Jürgen ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR ANTAGONIST; CYCLIC AMP; FORSKOLIN; INTERLEUKIN 4; METHANANDAMIDE; NUCLEOTIDE; OLIGONUCLEOTIDE; RECEPTOR PROTEIN; STAT6 PROTEIN;

ARTICLE; BINDING SITE; GENE CONTROL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; NEURAL STEM CELL; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR GENE; REPORTER GENE; T LYMPHOCYTE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ACETYLATION; CELLS, CULTURED; CHLORAMPHENICOL O-ACETYLTRANSFERASE; CYCLIC AMP; ELECTROPORATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENES, REPORTER; HUMANS; INTERLEUKIN-4; JURKAT CELLS; KINETICS; PIPERIDINES; PLASMIDS; PROMOTER REGIONS (GENETICS); PYRAZOLES; RECEPTOR, CANNABINOID, CB1; STAT6 TRANSCRIPTION FACTOR; STATISTICS AS TOPIC; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 40849147262     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.042945     Document Type: Article

References (23)

1. Ashton JC, Friberg D, Darlington CL, and Smith PF (2006) Expression of the cannabinoid CB2 receptor in the rat cerebellum: an immunohistochemical study. Neurosci Lett 396:113-116.
2. Börner C, Höllt V, and Kraus J (2006) Cannabinoid receptor type 2 agonists induce transcription of the μ-opioid receptor gene in Jurkat T cells. Mol Pharmacol 69:1486-1491.
3. Börner C, Höllt V, Sebald W, and Kraus J (2007) Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids. J Leukoc Biol 81:336-343.
4. Börner C, Kraus J, Schröder H, Ammer H, and Höllt V (2004a) Transcriptional regulation of the human mu-opioid receptor gene by interleukin-6. Mol Pharmacol 66:1719-1726.
5. Börner C, Wöltje M, Höllt V, and Kraus J (2004b) STAT6 transcription factor binding sites with mismatches within the canonical 5′-TTC.GAA-3′ motif involved in regulation of delta- and mu-opioid receptors. J Neurochem 91:1493-1500.
6. Brown AJ (2007) Novel cannabinoid receptors. Br J Pharmacol 152:567-575.
7. Curfs JH, Meis JF, and Hoogkamp-Korstanje JA (1997) A primer on cytokines: sources, receptors, effects, and inducers. Clin Microbiol Rev 10:742-780.
8. Daaka Y, Friedman H, and Klein TW (1996) Cannabinoid receptor proteins are increased in Jurkat, human T-cell line after mitogen activation. J Pharmacol Exp Ther 276:776-783.
9. Daaka Y, Klein TW, and Friedman H (1995) Expression of cannabinoid receptor mRNA in murine and human leukocytes. Adv Exp Med Biol 373:91-96.
10. Felder CC, Joyce KE, Briley EM, Mansouri J, Mackie K, Blond O, Lai Y, Ma AL, and Mitchell RL (1995) Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol 48:443-550.
11. Gong JP, Onaivi ES, Ishiguro H, Liu QR, Tagliaferro PA, Brusco A, and Uhl GR (2006) Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res 1071:10-23.
12. Horton JK, Martin RC, Kalinka S, Cushing A, Kitcher JP, O'Sullivan MJ, and Baxendale PM (1992) Enzyme immunoassays for the estimation of adenosine 3′,5′ cyclic monophosphate and guanosine 3′,5′ cyclic monophosphate in biological fluids. J Immunol Methods 155:31-40.
13. Hou J, Schindler U, Henzel WJ, Ho TC, Brasseur M, and McKnight SL (1994) An interleukin-4-induced transcription factor: IL-4 Stat. Science 265:1701-1706.
14. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, et al. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54:161-202.
15. Klein TW, Newton C, Larsen K, Chou J, Perkins I, Lu L, Nong L, and Friedman H (2004) Cannabinoid receptors and T helper cells. J Neuroimmunol 147:91-94.
16. Klein TW, Newton CA, Nakachi N, and Friedman H (2000) Delta 9-tetrahydrocannabinol treatment suppresses immunity and early IFN-gamma, IL-12, and IL-12 receptor beta 2 responses to Legionella pneumophila infection. J Immunol 164:6461-6466.
17. Kraus J, Börner C, Giannini E, and Höllt V (2003a) The role of nuclear factor κB in tumor necrosis factor-regulated transcription of the human μ-opioid receptor gene. Mol Pharmacol 64:876-884.
18. Kraus J, Börner C, and Höllt V (2003b) Distinct palindromic extensions of the 5′-TTC.GAA-3′ motif allow STAT6 binding in vivo. FASEB J 17:304-306.
19. Luckow B and Schütz G (1987) CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res 15:5490.
20. Molina-Holgado F, Pinteaux E, Moore JD, Molina-Holgado E, Guaza C, Gibson RM, and Rothwell NJ (2003) Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia. J Neurosci 23:6470-6474.
21. Nakajima Y, Furuichi Y, Biswas KK, Hashiguchi T, Kawahara K, Yamaji K, Uchimura T, Izumi Y, and Maruyama I (2006) Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-kappaB pathway inhibition. FEBS Lett 580:613-619.
22. O'Garra A and Arai N (2000) The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol 10:542-550.
23. Zhang PW, Ishiguro H, Ohtsuki T, Hess J, Carillo F, Walther D, Onaivi ES, Arinami T, and Uhl GR (2004) Human cannabinoid receptor 1: 5′ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse. Mol Psychiatry 9:916-931.